Northrook, IL -- (SBWIRE) -- 04/16/2020 -- The ongoing COVID-19 pandemic—and the worldwide reaction to it—has compelled companies to radically rethink their strategies and the way they operate. We salute the industry experts helping companies survive and sustain in this pandemic.

At MarketsandMarkets™, analysts are undertaking continuous efforts to provide analysis of the COVID-19 impact on the Next-generation Sequencing (NGS) Market. We are working diligently to help companies take rapid decisions by studying:

+ The impact of COVID-19 on the Next-generation Sequencing (NGS) Market, including growth/decline in product type/use cases due to the cascaded impact of COVID-19 on the extended ecosystem of the market
+ The rapid shifts in the strategies of the Top 50 companies in the Next-generation Sequencing (NGS) Market
+ The shifting short-term priorities of the top 50 companies' clients and their client's clients

You can request an in-depth analysis detailing the impact of COVID-19 on the Next-generation Sequencing (NGS) Market: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=546

According to the new market research report "Next-generation Sequencing (NGS) Market by Product (NOVASEQ, NEXTSEQ, SEQUEL, NANOPORE), Consumables, Bioinformatics, Services (EXOME, RNA, DENOVO), Technology (ION, SMRT), Application (Diagnostics, Cancer), End User, Region - Global Forecast to 2025", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).

The availability of advanced, efficient, and accurate NGS systems at a low cost, along with the reduced cost of sequencing overall, the increasing applications of NGS in diagnostics and genomics research, the availability of research funding, the development of NGS data analysis solutions, and the improving regulatory and reimbursement scenario for NGS-based diagnostic tests are some of the key factors driving the growth of Next-generation Sequencing Market.

The SBS segment accounted for the largest share of the NGS market, by technology, in 2018

On the basis of technology, the NGS Services Market is segmented into sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time (SMRT) sequencing, nanopore sequencing, and other sequencing technologies. In 2018, the SBS segment accounted for the largest share of the market. The dominant market position of this segment is mainly due to the development of new and advanced NGS platforms and the increasing demand for Illumina's systems, as it is the major provider of NGS platforms that use the SBS technology (including the HiSeq MiSeq series and NextSeq).

Browse in-depth TOC on "Next-generation Sequencing Market"
121 – Tables
39 – Figures
216 – Pages
Get 10% Customization Research Report:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=546

The diagnostics application segment accounted for the largest share of the NGS Market in 2018

Based on applications, the Next-generation Sequencing Market is segmented into diagnostics, drug discovery, agricultural & animal research, and other applications, which include marine research and research in biofuels, forensics, metagenomic studies, and evolutionary studies. Of all these application segments, diagnostics accounted for the largest share of the market in 2018. The large share of this segment can be attributed to the growing number of new cancer cases across the globe, favorable reimbursement scenario for NGS-based tests in the US, and increasing focus of key market players on developing NGS-based products & services for cancer and NIPT.

The academic institutes & research centers segment accounted for the largest share of the Next-generation Sequencing Market, by end user, in 2018

On the basis of end user, the market is segmented into academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. In 2018, the academic institutes & research centers segment accounted for the largest share of the NGS Services Market. This can be attributed to the increasing number of collaborations between NGS Market players and academic & research institutions, favorable funding scenario for genomic research across regions, and the development of cost-effective NGS products and services for researchers.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=546

North America accounted for the largest share of the NGS Services Market in 2018

North America accounted for the largest share of the Next-generation Sequencing Market in 2018, followed by Europe. This can primarily be attributed to factors such as increasing applications of NGS in diagnostics and genomics research, the availability of research funding, and the development of NGS data analysis solutions.

Leading Companies

Some of the prominent players in the Next-generation Sequencing Market include Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), BGI Group (China), PerkinElmer Inc. (US), Macrogen (South Korea), Hamilton Company (US), Lucigen (US), Intrexon Bioinformatics GmbH (Germany), Partek Incorporated (US), DNASTAR, Inc. (US), DNAnexus (US), SciGenom Labs Pvt. Ltd. (India), GENEWIZ (US), Takara Bio Inc. (Japan), Eurofins Scientific (Luxembourg), 10x Genomics (US), F. Hoffmann-La Roche Ltd. (Switzerland), Becton Dickinson and Company (US), Danaher (US), Lexogen GmbH (Austria), Tecan Trading AG (Switzerland), Zymo Research (US), Oxford Nanopore Technologies (UK), Agilent Technologies, Inc. (US), and QIAGEN (Netherlands).